Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro can affect how well the oral contraceptive pill is absorbed. Because tirzepatide slows gastric emptying, the pill may pass through your stomach more slowly than usual, which can reduce how much of it reaches your bloodstream. The MHRA and NHS advise women starting tirzepatide to use an additional, non-oral method of contraception (such as condoms) for the first four weeks of treatment and for four weeks after every dose increase. This is a practical precaution, not a reason to avoid treatment; it simply means planning ahead with your GP or prescriber before you begin. Mounjaro is a prescription-only weight-management medicine, so a prescriber will always discuss your full medical picture, including contraception, before approving treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a question our prescribers hear most weeks, usually from women who were handed a starter pen and a vague instruction to 'sort out their contraception'. The worry is real and the answer is specific, so here it is plainly.
Tirzepatide works partly by slowing how quickly your stomach empties its contents into the small intestine. That mechanism is behind much of the appetite reduction it produces. The problem is that the same slowdown affects everything you swallow, including the oral contraceptive pill. The pill relies on timely absorption from the gut; when gastric emptying drags, absorption can be incomplete or delayed, and the hormonal levels needed to prevent ovulation may not be reliably reached.
This is distinct from a drug interaction in the traditional sense. Mounjaro is not chemically blocking the pill or speeding its breakdown by the liver. The effect is mechanical and tied to gut-transit time. Understanding how tirzepatide works at a physiological level makes this clearer: the GIP and GLP-1 receptor activation that drives weight loss also modulates the speed of digestion throughout the day.
The misconception worth setting aside gently is that this only matters at higher doses. The slowing of gastric emptying begins at 2.5 mg (the very first pen) and is present throughout treatment, which is exactly why the guidance covers those initial four weeks and every subsequent dose increase.
The guidance here is unambiguous. NHS England's information on weight-management injections, and parallel NHS Inform Scotland advice, both state that women using oral contraceptives should add a reliable non-oral method of contraception for the first four weeks of starting tirzepatide and for four weeks after each dose increase. Condoms are the most straightforward addition; the patch, implant, or hormonal coil are alternatives worth discussing with your GP.
Importantly, the same guidance notes there is no equivalent evidence of reduced pill effectiveness for semaglutide (Wegovy). This recommendation is specific to tirzepatide. If you are considering switching between treatments, that distinction matters, you can read more about how Mounjaro interacts with the coil specifically, since long-acting methods are handled differently.
The four-week window after each dose increase is not arbitrary. Each step up in dose (from 2.5 mg through to higher maintenance doses) resets the degree of gastric slowing while your body adjusts. The prescribing SmPC, published on the electronic Medicines Compendium, specifies this schedule, and it is the authoritative reference for exact timings. Our prescribers also check whether HRT is part of the picture, since NHS England advises considering transdermal formulations of HRT for the same absorption reason.
If you have a non-oral contraceptive already (an IUD, implant, hormonal patch, or injection) you do not need to add anything. Those methods are absorbed systemically, not through the gut, and Mounjaro's effect on gastric emptying does not apply to them.
Tell your prescriber or GP what contraception you use before starting Mounjaro. This is a standard part of the clinical review at nume: a real clinician reads your consultation answers the same day, not software, and contraception is one of the things checked. If you are currently on the combined or progestogen-only pill, the prescriber can confirm whether your specific formulation has any additional considerations and advise on the backup method.
If you are thinking about becoming pregnant, the picture changes. Tirzepatide is not recommended during pregnancy, whilst breastfeeding, or when actively trying to conceive. Your prescriber will advise on an appropriate wash-out period before conception attempts begin, in line with MHRA guidance.
Some women find the prospect of managing an additional contraceptive method disruptive enough to consider switching to a long-acting method while on treatment. That is a conversation worth having with your GP before you start, not after. If any changes to your periods concern you during treatment, our page on how Mounjaro affects periods covers what is known and what to raise with a clinician.
Treatment costs and what a private prescription includes are covered on our Mounjaro prices page if that context is useful at this stage.
If you started Mounjaro without knowing about this guidance, or you have been through several dose increases without using additional contraception, speak to a clinician promptly. The aim is not to alarm you; unintended pregnancy is a risk that can be managed when raised quickly.
Yellow Card, the MHRA's reporting system at yellowcard.mhra.gov.uk, is where patients can flag suspected side effects or unexpected outcomes, including anything that raises concerns during treatment. The NHS England guidance on weight-management injections at england.nhs.uk is also the clearest single reference for contraception and HRT advice in this context.
If you have questions before starting, our prescribers are available through a free consultation. You can also read more about the medicine itself on our Mounjaro and the pill overview, or explore weight-loss treatment options more broadly. When you are ready, start your free consultation and a prescriber will review your full medical history (including your contraception) the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.